Skip to main content

Table 3 Final model for the stepwise Cox hazard model analysis showing Hazard Ratio (with relative confidence intervals and p-values) for worsening in disability after the increase of IFNB dose.

From: Management of breakthrough disease in patients with multiple sclerosis: when an increasing of Interferon beta dose should be effective?

 

HR

95% C.I.

p-value

Male gender

1.68

0.88 - 2.13

0.1

Age at switch (each year)

0.98

0.94 - 1-02

0.3

Interaction term (relapse * active MRI scan at switch)

2.14

1.16 - 3.96

0.01

EDSS score at switch (each point)

1.77

1.39 - 2.26

< 0.001

IFNB type (Betaferon or Rebif 44)

0.83

0.28 - 2.85

0.7

  1. IFNB: Interferon Beta; EDSS: Expanded Disability Status Scale.